ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Endometrial Cancer
Ovarian Epithelial Carcinoma
Breast Cancer
Cancer
Fallopian Tube Cancer
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Ovarian Cancer trials near Salt Lake City, UT, USA:

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) (DO-01)

in participants with human epidermal growth factor 2 (HER2)-expressing (immunohistochemistry \[IHC\] 3+/2+/1+) advanced high-grade epithelial ovarian...

Enrolling
Ovarian Cancer
Drug: Trastuzumab Deruxtecan
Drug: Bevacizumab

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Salt Lake City, Utah, United States and 207 other locations

liposomal doxorubicin (PLD), and to compare the efficacy and safety of NP-G2-044+PLD vs. PLD alone in participants with platinum-resistant ovarian...

Active, not recruiting
Platinum-resistant Ovarian Cancer
Drug: NP-G2-044
Drug: PLD

Phase 2, Phase 3

Novita Pharmaceuticals

Salt Lake City, Utah, United States and 5 other locations

followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...

Active, not recruiting
Advanced Ovarian Cancer
Drug: Bevacizumab
Drug: Durvalumab placebo

Phase 3

AstraZeneca
AstraZeneca

Salt Lake City, Utah, United States and 213 other locations

Ovarian cancer (OC) is a lethal disease. The purpose of this study is to assess the safety, pharmacokinetics and efficacy of ABBV90 ...

Enrolling
Ovarian Cancer
Drug: ABBV-901
Drug: Bevacizumab

Phase 1

AbbVie
AbbVie

West Valley City, Utah, United States and 16 other locations

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...

Enrolling
Low Grade Serous Ovarian Cancer
Drug: Defactinib
Drug: Letrozole

Phase 3

Verastem

Murray, Utah, United States and 106 other locations

Researchers are looking for other ways to treat high-grade serous and certain other ovarian cancer. High-grade means the cancer...

Enrolling
Ovarian Cancer Recurrent
Biological: Bevacizumab
Drug: MK-2010

Phase 1, Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

West Valley City, Utah, United States and 32 other locations

(PFS) in women with high-grade, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, expressing hig...

Enrolling
Epithelial Ovarian Cancer
Drug: Topotecan
Drug: Mirvetuximab Soravtansine (MIRV)

Phase 3

AstraZeneca
AstraZeneca

Salt Lake City, Utah, United States and 298 other locations

To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer...

Active, not recruiting
Chemotherapy-induced Thrombocytopenia
Drug: Placebo
Drug: Romiplostim

Phase 3

Amgen
Amgen

Ogden, Utah, United States of America and 139 other locations

female participants with recurrent or difficult to treat epithelial ovarian, primary peritoneal or fallopian tube cancer.This study...

Enrolling
Epithelial Ovarian Cancer
Fallopian Tube Cancer
Drug: Cemiplimab
Other: 27T51

Phase 1

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Salt Lake City, Utah, United States and 4 other locations

This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With C...

Enrolling
Ovarian Cancer
Drug: INCB123667

Phase 2

Incyte
Incyte

Salt Lake City, Utah, United States and 73 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems